NCT07254091 2026-03-06
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer
Northwell Health
Phase EARLY_PHASE1 Recruiting
Clinical Trials
49 trialsNCT04005690 2026-02-27
Targeted Pathway Inhibition in Patients With Pancreatic Cancer
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Recruiting
NCT06511037 2026-02-27
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
University of California, Irvine
Phase EARLY_PHASE1 Recruiting
NCT07193862 2026-02-27
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis
Northwell Health
Phase EARLY_PHASE1 Recruiting
NCT07416240 2026-02-18
Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer.
Hainan Cancer Hospital
Phase EARLY_PHASE1 Recruiting
NCT07236177 2026-02-05
B-GLUCANCER2
Poitiers University Hospital
Phase EARLY_PHASE1 Recruiting
NCT07378436 2026-01-30
A Clinical Study of GK02 in Malignant Ascites
Beijing Geekgene Technology Co., LTD
Phase EARLY_PHASE1 Recruiting
NCT07242417 2026-01-21
TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors
Beijing GoBroad Hospital
Phase EARLY_PHASE1 Recruiting
NCT06653023 2026-01-20
Wondercel-UWD3
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Recruiting
NCT06653010 2026-01-16
Wondercel-UWD1
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Recruiting
NCT07343791 2026-01-15
Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Third-line Treatment for Advanced Colorectal Cancer.
Jinling Hospital, China
Phase EARLY_PHASE1 Recruiting
NCT05041153 2026-01-12
Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT04930991 2026-01-08
OU202005AJ
University of Oklahoma
Phase EARLY_PHASE1 Recruiting
NCT05086250 2026-01-07
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Recruiting
NCT06645808 2025-12-29
VARTUTRACE
Var2 Pharmaceuticals
Phase EARLY_PHASE1 Recruiting
NCT04960072 2025-12-23
A Study of GC101 TIL in r/r Gastrointestinal Tumors (10hospital)
Shanghai Juncell Therapeutics
Phase EARLY_PHASE1 Recruiting
NCT07295262 2025-12-19
NIR-II Fluorescence-Guided Hepatectomy Using ICG-Cisplatin Nanoprobes for HCC
West China Hospital
Phase EARLY_PHASE1 Recruiting
NCT05098197 2025-12-11
A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)
Shanghai Juncell Therapeutics
Phase EARLY_PHASE1 Recruiting
NCT04975217 2025-11-21
Fecal Microbial Transplants for the Treatment of Pancreatic Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT06496373 2025-11-17
Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer
Ruijin Hospital
Phase EARLY_PHASE1 Recruiting
NCT07229768 2025-11-17
Clinical Study of 177Lu-CTR-FAPI In the Treatment of Patients With Advanced, Metastatic Solid Tumors
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1 Recruiting
NCT07167446 2025-10-22
Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy
Fox Chase Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT07198659 2025-09-30
NeuMed-uPC
The First Affiliated Hospital of Air Force Medicial University
Phase EARLY_PHASE1 Recruiting
NCT07106814 2025-09-15
Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors
Anhui Provincial Hospital
Phase EARLY_PHASE1 Recruiting
NCT05438667 2025-09-08
TCR-T Cell Therapy on Advanced Solid Tumors
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase EARLY_PHASE1 Recruiting
NCT07050394 2025-07-03
A Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer
Shanghai Changzheng Hospital
Phase EARLY_PHASE1 Recruiting
NCT07034742 2025-06-24
Exploratory Study on the Application of Molecular Residual Disease (MRD) in Postoperative Treatment of Gastric Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1 Recruiting
NCT04665947 2025-05-28
First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer
University of California, Davis
Phase EARLY_PHASE1 Recruiting
NCT06577532 2025-05-21
Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors
Ruijin Hospital
Phase EARLY_PHASE1 Recruiting
NCT06675513 2025-05-20
Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Recruiting
NCT06406816 2025-05-15
Neoantigen Vaccine Plus Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma After Radical Resection
Meng Chao Hepatobiliary Hospital of Fujian Medical University
Phase EARLY_PHASE1 Recruiting
NCT06383520 2025-05-14
Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1 Recruiting
NCT06418659 2025-04-24
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients
Shanghai Changzheng Hospital
Phase EARLY_PHASE1 Recruiting
NCT06937567 2025-04-22
CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
Zhejiang University
Phase EARLY_PHASE1 Recruiting
NCT02172651 2025-04-20
Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases
Dana-Farber Cancer Institute
Phase EARLY_PHASE1 Recruiting
NCT05365893 2025-04-16
PHL Treatment in Pancreatic Cancer
Fox Chase Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT04601428 2025-03-06
Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC)
Koo Foundation Sun Yat-Sen Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT04048278 2025-03-03
Lidocaine Infusion in Pancreatic Cancer
University of Illinois at Chicago
Phase EARLY_PHASE1 Recruiting
NCT06478459 2024-12-27
Endoscopic Ultrasound (EUS) Intratumoral Injection of CAR-NK Cells in the Treatment of Advanced Pancreatic Cancer
Zhejiang University
Phase EARLY_PHASE1 Recruiting
NCT06503497 2024-12-27
A Trail of Second-line Chemotherapy Sequential NKG2D CAR-NK Cell Therapy for Pancreatic Cancer
Zhejiang University
Phase EARLY_PHASE1 Recruiting
NCT06652243 2024-11-25
SN301A
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1 Recruiting
NCT06690476 2024-11-15
Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of IPM514 in Patients with Esophageal Squamous Cell Carcinoma
Peking University
Phase EARLY_PHASE1 Recruiting
NCT06446050 2024-06-06
Chemokine and Co-stimulatory Molecule-modified Mesenchymal Stem Cells for the Treatment of Advanced Colorectal Cancer
Shanghai East Hospital
Phase EARLY_PHASE1 Recruiting
NCT05359146 2024-04-19
Beta plus
University Hospital, Basel, Switzerland
Phase EARLY_PHASE1 Recruiting
NCT06327269 2024-04-18
Innovative Diagnosis and Therapy in LDLT Patients With High-risk Hepatocellular Carcinoma
Chang Gung Memorial Hospital
Phase EARLY_PHASE1 Recruiting
NCT06326736 2024-03-22
Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer
Jinling Hospital, China
Phase EARLY_PHASE1 Recruiting
NCT06104241 2023-10-27
BGT007 Cells for the Treatment of Refractory Digestive System Tumors
The Affiliated Hospital of Xuzhou Medical University
Phase EARLY_PHASE1 Recruiting
NCT05916261 2023-10-26
Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer
Ruijin Hospital
Phase EARLY_PHASE1 Recruiting
NCT05583201 2023-02-08
NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumors
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Phase EARLY_PHASE1 Recruiting